product liability

What is Happening with the Elmiron Vision Loss Lawsuits?

Elmiron, a popular prescription drug used to treat interstitial cystitis (IC), has been at the center of controversy and legal action in recent years. Thousands of former Elmiron users have filed lawsuits claiming that long-term use of the interstitial cystitis medication has caused them to suffer vision loss and other serious eye conditions. Research has […]

What is Happening with the Elmiron Vision Loss Lawsuits? Read More »

Latest Roundup Trial Ends in Staggering $1.5 Billion Verdict over Cancer Claims

In a recent landmark decision, Bayer AG’s subsidiary, Monsanto, was ordered by a Missouri jury to pay a staggering $1.56 billion in damages in the latest Roundup trial. The verdict, one of the largest in the five-year litigation over Roundup, comes as a major blow to the German pharmaceutical and chemical company, raising new questions

Latest Roundup Trial Ends in Staggering $1.5 Billion Verdict over Cancer Claims Read More »

Suboxone Dental Decay Lawsuits: How the Drug Causes Long-Term Damage to Teeth

Suboxone, a medication used to treat opioid addiction, has been touted as a safe and effective drug since its introduction in 2002. However, recent lawsuits against the drug manufacturer, Indivior, suggest that Suboxone may cause long-term dental damage and tooth decay. Former users have reported severe dental decay, tooth loss, and other serious oral health

Suboxone Dental Decay Lawsuits: How the Drug Causes Long-Term Damage to Teeth Read More »

Understanding and Managing Adverse Events in Patients Treated with Tepezza

Tepezza (teprotumumab) has emerged as a groundbreaking treatment for thyroid eye disease, offering hope to patients with this rare condition. Approved by the FDA in January 2020, Tepezza has shown remarkable efficacy in reducing eye bulging and double vision. However, like any medication, it is important to be aware of the potential adverse events associated

Understanding and Managing Adverse Events in Patients Treated with Tepezza Read More »

Bard Implantable Port Lawsuit: A Closer Look at Port-a-Caths and Their Risks

In recent years, there has been a significant increase in the number of product liability lawsuits related to Bard implantable port devices, commonly known as port-a-caths. Port-a-caths, manufactured by companies like Becton, Dickinson and Company, C.R. Bard, and Bard Access Systems, are designed to facilitate the delivery of medication and fluids to patients through an

Bard Implantable Port Lawsuit: A Closer Look at Port-a-Caths and Their Risks Read More »

Suboxone Lawsuit Filed Over Tooth Decay Side Effects

Suboxone, a medication commonly prescribed for opioid addiction, has recently come under scrutiny for its potential to cause serious dental problems in patients. One individual, David Sorensen, recently filed a product liability lawsuit against the manufacturers of Suboxone, claiming that the opioid addiction drug’s high acidity caused him to suffer tooth decay and permanent dental

Suboxone Lawsuit Filed Over Tooth Decay Side Effects Read More »

Pulmonary Embolism, Migration to the Heart Leads to Bard Infuse-A-Port Lawsuit

In the world of medical treatments, port-a-caths, also known as implantable ports or subcutaneous ports, have become a common tool for delivering medications and fluids directly into a patient’s bloodstream. These devices, which are implanted under the skin, provide healthcare professionals with easy access to a patient’s veins, making treatments such as chemotherapy more convenient

Pulmonary Embolism, Migration to the Heart Leads to Bard Infuse-A-Port Lawsuit Read More »

California Jury Awards $332 Million in Roundup Trial Over Non-Hodgkin’s Lymphoma

Earlier this week, pharmaceutical and biotechnology giant Bayer was ordered to pay $332 million in damages to a man who claimed his cancer was caused by exposure to the company’s Roundup weed killer. The verdict includes $7 million in compensatory damages and $325 million in punitive damages designed to punish the company for failing to

California Jury Awards $332 Million in Roundup Trial Over Non-Hodgkin’s Lymphoma Read More »

Roundup Verdict: Bayer Ordered to Pay $175 Million in Latest Cancer Trial

In a significant blow to pharmaceutical giant Bayer AG, a Philadelphia jury on Friday ordered the company to pay $175 million in damages in a trial involving their widely-used weed killer, Roundup. The plaintiff, retired restaurant owner Ernest Caranci, claimed that his prolonged exposure to Roundup caused him to develop non-Hodgkin’s lymphoma. This and a

Roundup Verdict: Bayer Ordered to Pay $175 Million in Latest Cancer Trial Read More »

Port-a-Cath

Did You Suffer Complications From a Port-a-Cath Device? Port-a-Caths, also known as implanted ports, can result in serious injuries such as catheter failure, fracture, infection, and migration. Victims of these injuries may be eligible to seek compensation through product liability lawsuits. Start My Port-a-Cath Fracture Lawsuit Claim Now Please enable JavaScript in your browser to

Port-a-Cath Read More »

Scroll to Top